PT749317E - Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade - Google Patents

Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade

Info

Publication number
PT749317E
PT749317E PT95913668T PT95913668T PT749317E PT 749317 E PT749317 E PT 749317E PT 95913668 T PT95913668 T PT 95913668T PT 95913668 T PT95913668 T PT 95913668T PT 749317 E PT749317 E PT 749317E
Authority
PT
Portugal
Prior art keywords
bactericid
proteins
therapeutic applications
permeability induced
dimeric
Prior art date
Application number
PT95913668T
Other languages
English (en)
Inventor
Roger G Little
William Steve Ammons
Original Assignee
Xoma Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Technology Ltd filed Critical Xoma Technology Ltd
Publication of PT749317E publication Critical patent/PT749317E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT95913668T 1994-03-11 1995-03-13 Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade PT749317E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/212,132 US5447913A (en) 1994-03-11 1994-03-11 Therapeutic uses of bactericidal/permeability-increasing protein dimer products

Publications (1)

Publication Number Publication Date
PT749317E true PT749317E (pt) 2002-11-29

Family

ID=22789691

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95913668T PT749317E (pt) 1994-03-11 1995-03-13 Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade

Country Status (12)

Country Link
US (4) US5447913A (pt)
EP (1) EP0749317B1 (pt)
JP (1) JPH09510217A (pt)
AT (1) ATE218879T1 (pt)
AU (1) AU703134B2 (pt)
CA (1) CA2185155C (pt)
DE (1) DE69527049T2 (pt)
DK (1) DK0749317T3 (pt)
ES (1) ES2180629T3 (pt)
HK (1) HK1014159A1 (pt)
PT (1) PT749317E (pt)
WO (1) WO1995024209A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198541A (en) * 1987-08-11 1993-03-30 New York University Dna encoding bactericidal/permeability-increasing proteins
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5627153A (en) * 1994-01-14 1997-05-06 Xoma Corporation Anti-fungal methods and materials
US5447913A (en) * 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
US5912228A (en) 1995-01-13 1999-06-15 Xoma Corporation Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
AU727085B2 (en) * 1995-07-20 2000-11-30 Xoma Corporation Anti-fungal peptides
AU730307B2 (en) * 1995-11-14 2001-03-01 Xoma Corporation Bactericidal permeability increasing protein (BPI) for treating conditions associated with corneal injury
US5686414A (en) * 1995-11-14 1997-11-11 Xoma Corporation Methods of treating conditions associated with corneal transplantation
WO1997042966A1 (en) 1996-05-10 1997-11-20 Xoma Corporation Therapeutic uses of bpi protein products for human meningococcemia
US5741779A (en) * 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
CA2255539C (en) * 1996-05-23 2005-09-27 Xoma Corporation Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
EP0939766A2 (en) * 1996-05-24 1999-09-08 The Regents Of The University Of Minnesota Synthesis of soluble beta-sheet forming peptides
US5888973A (en) * 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) * 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
NZ335401A (en) * 1996-11-01 2000-12-22 Xoma Corp Therapeutic uses of BPI protein products in cystic fibrosis patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
US20050159343A1 (en) * 1999-03-26 2005-07-21 Board Of Regents, University Of Texas System Inhibitors of glycosaminoglycans
WO2001003724A1 (en) * 1999-07-12 2001-01-18 Xoma Technology Ltd. Therapeutic uses of bpi protein products for inhibiting h+/k+ atpase activity
WO2001053335A2 (en) * 2000-01-20 2001-07-26 Regents Of The University Of Minnesota Peptides with antibacterial activity
US6686180B2 (en) * 2000-04-04 2004-02-03 Baxter International Inc. Method for the production of bacterial toxins
WO2002055099A2 (en) * 2000-12-01 2002-07-18 Xoma Technology Ltd Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
CA2476427A1 (en) 2002-02-20 2003-08-28 Regents Of The University Of Minnesota Partial peptide mimetics and methods
US7192737B2 (en) 2002-03-29 2007-03-20 Xoma Technology Ltd. Methods and materials for increasing expression of recombinant polypeptides
US20040037895A1 (en) * 2002-08-23 2004-02-26 Alex Zhu Methods of treating involuntary facial spasms and facial wrinkles
EP1741440A1 (en) 2005-07-08 2007-01-10 Mellitus S.L. Use of BPI protein for the treatment of disorders of the metabolism and cardiovascular disorders
BRPI0916323A2 (pt) * 2008-07-21 2018-05-29 Otonomy Inc composições antimicrobianas de liberação controlada e métodos para o tratamento de distúrbios do ouvido
GB201319621D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
CN117686438B (zh) * 2024-02-02 2024-05-10 东北大学秦皇岛分校 一种基于红外偏振光的远程材料鉴别方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198541A (en) * 1987-08-11 1993-03-30 New York University Dna encoding bactericidal/permeability-increasing proteins
US5089274A (en) * 1989-02-14 1992-02-18 Incyte Pharmaceuticals, Inc. Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
WO1993023434A2 (en) * 1992-05-19 1993-11-25 Xoma Corporation Bpi-immunoglobulin fusion proteins
CA2276548C (en) * 1992-05-19 2001-07-31 Xoma Corporation Improved methods for the preparation of endotoxin-binding proteins
CN1163264C (zh) * 1993-02-02 2004-08-25 爱克索马技术有限公司 改进的药物组合物
US5420019A (en) * 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
AU694108B2 (en) * 1993-03-12 1998-07-16 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
CA2157925C (en) * 1993-03-12 2000-06-06 Lewis H. Lambert, Jr. Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
CN1105574C (zh) * 1993-03-12 2003-04-16 爱克索马技术有限公司 杀菌/增强通透性蛋白质产物的治疗用途
US5627153A (en) * 1994-01-14 1997-05-06 Xoma Corporation Anti-fungal methods and materials
US5348942A (en) * 1993-03-12 1994-09-20 Xoma Corporation Therapeutic uses of bactericidal/permeability increasing protein products
US5733872A (en) * 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
WO1995002414A1 (en) * 1993-07-14 1995-01-26 Xoma Corporation Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products
PT759774E (pt) * 1993-09-22 2002-11-29 Xoma Technology Ltd Metodo para o tratamento de infeccoes bacterianas gram-negativas por administracao de um produto de proteina bactericida indutora da permeabilidade (bip) e de um antibiotico
EP0722333B1 (en) * 1993-10-05 2004-06-16 XOMA Technology Ltd. Bpi-protein-products for depressed reticuloendothelial system function
DE69527195T2 (de) * 1994-01-14 2003-03-06 Xoma Technology Ltd., Berkeley Anti gram positive bakterielle verfahren und mittel
US5643875A (en) * 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
US5447913A (en) * 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
US5578568A (en) * 1994-04-22 1996-11-26 Xoma Corporation Method of treating conditions associated with intestinal ischemia/reperfusion
US5912228A (en) * 1995-01-13 1999-06-15 Xoma Corporation Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
US5494896A (en) * 1995-03-31 1996-02-27 Xoma Corporation Method of treating conditions associated with burn injuries

Also Published As

Publication number Publication date
WO1995024209A1 (en) 1995-09-14
ES2180629T3 (es) 2003-02-16
EP0749317A1 (en) 1996-12-27
HK1014159A1 (en) 1999-09-24
CA2185155A1 (en) 1995-09-14
DK0749317T3 (da) 2002-10-07
AU1996995A (en) 1995-09-25
US6277821B1 (en) 2001-08-21
ATE218879T1 (de) 2002-06-15
JPH09510217A (ja) 1997-10-14
CA2185155C (en) 2001-08-14
US5856302A (en) 1999-01-05
EP0749317B1 (en) 2002-06-12
US5447913A (en) 1995-09-05
US5703038A (en) 1997-12-30
DE69527049D1 (de) 2002-07-18
AU703134B2 (en) 1999-03-18
DE69527049T2 (de) 2003-03-06

Similar Documents

Publication Publication Date Title
PT749317E (pt) Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade
FR13C0021I2 (fr) Conjugates d'exendin-4 et leur utilisation medicale
FI962154A0 (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
ATE169304T1 (de) Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung
IL101348A0 (en) Polyethylene glycol protein conjugates,their preparation and pharmaceutical compositions containing them
MXPA03001673A (es) Bacteria de acido lactico capaz de reducir una tendencia individual a desarrollar reacciones alergicas.
ATE256186T1 (de) Verwendungen von angiogenischer factor vegf145 in der behandlung von kardiovaskulaeren krankheiten
SE9804614D0 (sv) New peptides and use thereof
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
ATE179211T1 (de) Menschliche il-3-varianten
RU95106680A (ru) Бициклические ароматические соединения и содержащие их фармацевтические и косметические композиции
TR200100637T2 (tr) Yeni doğal ürün türevleri
IT1270618B (it) Proteine ad attivita' antitumorale
GR880100775A (el) Παράγοντας ενεργοποιήσεως ουδετεροφίλων.
DK1165102T3 (da) Matrixproteinpræparater til podning i ikke-mineraliseret væv
MX9805065A (es) Nuevos derivados bi-aromaticos del dibenzofurano y su utilizacion en medicina humana o veterinaria asi como en cosmetica.
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE69718047D1 (de) Therapeutische verwendung von bpi proteineprodukten bei patienten mit zystischer fibrose
DE59107240D1 (de) Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung
DE69323191D1 (de) Wasserlösliche retinoide
DE59611330D1 (de) Arzneimittel enthaltend wenigstens einen teil des ul84-proteins des cytomegalovirus, verwendung von polypeptiden entsprechend der aminosäuresequenz des ul84-proteins und verfahren zur einführung von ul84 in zielzellen
ES2067058T3 (es) Tratamiento de carnes.
FR2679909B1 (fr) Polypeptides aptes a induire in vivo des anticorps inhibant l'invasion de globules rouges par des merozouites de p. falciparum, produits apparentes et leur application comme vaccin.
ITPC930011A0 (it) Composizione cosmetica contenente proteine dello yogurt ed estratto dibetulla, per la reparazione di prootti tricologici.
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.